Cargando…
Engineered Cell-Based Therapeutics: Synthetic Biology Meets Immunology
Synthetic Biology has enabled new approaches to several medical applications including the development of immunotherapies based on bioengineered cells, and most notably the engineering of T-cells with tumor-targeting receptors, the Chimeric Antigen Receptor (CAR)-T cells. CAR-T-cells have successful...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431652/ https://www.ncbi.nlm.nih.gov/pubmed/30937303 http://dx.doi.org/10.3389/fbioe.2019.00043 |